Advanced Search

Technical Analysis for KNSA - Kiniksa Pharmaceuticals, Ltd.

Grade Last Price % Change Price Change
grade D 20.0 1.52% 0.30
KNSA closed up 1.52 percent on Monday, August 10, 2020, on 77 percent of normal volume. The price action carved out a bearish shooting star candlestick pattern. That may indicate a downside reversal. Look for price to trade beneath the low of the shooting star for confirmation. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.
1 Watcher
Watchlist Portfolio

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Down Up
Historical KNSA trend table...
Date Alert Name Type % Chg
Shooting Star Candlestick Bearish 0.00%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.00%
Oversold Stochastic Weakness 0.00%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 1.52%
Oversold Stochastic Weakness 1.52%
Oversold Stochastic Weakness 2.04%
Slingshot Bearish Bearish Swing Setup 1.16%
Stochastic Buy Signal Bullish 1.16%
Outside Day Range Expansion 1.16%
Oversold Stochastic Weakness 1.16%
Older EOD signals for KNSA ...
View Intraday Alerts

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Get Started for Free!
Configure default chart indicators Basic chart:

Profile

Kiniksa Pharmaceuticals Ltd is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing and commercializing therapeutic medicines for patients suffering from debilitating diseases.
Biotechnology Health Biopharmaceutical Pharmaceutical Industry Diseases Medication Pharmacology

Is KNSA a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Counts: 1 bullish, 2 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

Recent News

Date Title
Aug 4 Kiniksa Pharmaceuticals to Present at the 2020 Wedbush PacGrow Healthcare Conference
Jul 30 Kiniksa Pharmaceuticals EPS misses by $0.10
Jul 30 Kiniksa Reports Second Quarter 2020 Financial Results and Highlights Recent Pipeline and Corporate Activity
Jul 28 Do Insiders Own Lots Of Shares In Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA)?
Jul 22 Kiniksa Pharma prices stock offering at $21
Jul 22 Kiniksa Pharmaceuticals, Ltd. Announces Pricing of Upsized Public Offering
Jul 21 45 Stocks Moving in Tuesday's Pre-Market Session
Jul 20 Kiniksa launches $100M stock offering
Jul 20 Kiniksa Pharma to raise $100M in equity
Jul 16 Kiniksa Announces U.S. Orphan Drug Designation for Rilonacept for the Treatment of Pericarditis
See more KNSA news...

Indicators

Indicator Value
52 Week High 28.67
52 Week Low 5.01
Average Volume 348,776
200-Day Moving Average 16.65
50-Day Moving Average 22.26
20-Day Moving Average 20.71
10-Day Moving Average 19.64
Average True Range 1.19
ADX 10.76
+DI 19.75
-DI 20.04
Chandelier Exit (Long, 3 ATRs ) 20.93
Chandelier Exit (Short, 3 ATRs ) 22.53
Upper Bollinger Band 23.48
Lower Bollinger Band 17.94
Percent B (%b) 0.37
BandWidth 26.76
MACD Line -0.83
MACD Signal Line -0.82
MACD Histogram -0.0073
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 21.07
Resistance 3 (R3) 21.11 20.80 20.89
Resistance 2 (R2) 20.80 20.53 20.78 20.83
Resistance 1 (R1) 20.40 20.36 20.60 20.36 20.77
Pivot Point 20.09 20.09 20.19 20.07 20.09
Support 1 (S1) 19.69 19.82 19.89 19.65 19.23
Support 2 (S2) 19.38 19.65 19.36 19.17
Support 3 (S3) 18.98 19.38 19.11
Support 4 (S4) 18.94